Trying to separate three different claims about oxiracetam: that it is the right molecule, that it is the right dose, and that it does something useful.
The animal data is stronger than the human data and the human data is not nothing, it is just small.
Baseline first. Without a baseline the after picture is decoration.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
Sample size, blinding, and who paid for it. Those three questions kill most of the confidence in most of these threads.
Happy to be corrected on any of the above.
Is a baseline blood test really necessary before starting something like this? Currently on oxiracetam myself.
Same here.
Sleep, food, or the compound? Yes.
Stupid question: how do you know whether what is in the vial matches the label at all?
Narrow conclusion, briefly right. Broad conclusion, interestingly wrong. I know which I keep choosing.